Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.

Philip P, Chaufton C, Taillard J, Capelli A, Coste O, Léger D, Moore N, Sagaspe P.

Sleep. 2014 Mar 1;37(3):483-7. doi: 10.5665/sleep.3480.

2.

Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.

Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A.

J Sleep Res. 2015 Feb;24(1):74-81. doi: 10.1111/jsr.12201. Epub 2014 Sep 5.

4.

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.

Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF.

Neurology. 1997 Aug;49(2):444-51.

PMID:
9270575
6.

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.

Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):74-9. Erratum in: Clin Neuropharmacol. 2004 May-Jun;27(3):152.

PMID:
15252267
7.

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.

Curr Med Res Opin. 2006 Apr;22(4):761-74.

PMID:
16684437
8.

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.

Sleep. 2002 Dec;25(8):905-9.

PMID:
12489899
9.

Effects of armodafinil on simulated driving and alertness in shift work disorder.

Drake C, Gumenyuk V, Roth T, Howard R.

Sleep. 2014 Dec 1;37(12):1987-94. doi: 10.5665/sleep.4256.

10.

Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding CL, Lecomte JM, Schwartz JC; HARMONY I study group.

Lancet Neurol. 2013 Nov;12(11):1068-75. doi: 10.1016/S1474-4422(13)70225-4. Epub 2013 Oct 7.

PMID:
24107292
11.

Maintenance of Wakefulness Test scores and driving performance in sleep disorder patients and controls.

Philip P, Chaufton C, Taillard J, Sagaspe P, Léger D, Raimondi M, Vakulin A, Capelli A.

Int J Psychophysiol. 2013 Aug;89(2):195-202. doi: 10.1016/j.ijpsycho.2013.05.013. Epub 2013 May 28.

PMID:
23727627
12.

Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test.

van der Heide A, van Schie MK, Lammers GJ, Dauvilliers Y, Arnulf I, Mayer G, Bassetti CL, Ding CL, Lehert P, van Dijk JG.

Sleep. 2015 Jul 1;38(7):1051-8. doi: 10.5665/sleep.4810.

13.

Modafinil Increases Awake EEG Activation and Improves Performance in Obstructive Sleep Apnea during Continuous Positive Airway Pressure Withdrawal.

Wang D, Bai XX, Williams SC, Hua SC, Kim JW, Marshall NS, D'Rozario A, Grunstein RR.

Sleep. 2015 Aug 1;38(8):1297-303. doi: 10.5665/sleep.4912.

14.

Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.

Chapman JL, Kempler L, Chang CL, Williams SC, Sivam S, Wong KK, Yee BJ, Grunstein RR, Marshall NS.

Thorax. 2014 Mar;69(3):274-9. doi: 10.1136/thoraxjnl-2013-203796. Epub 2013 Nov 28.

PMID:
24287166
15.

Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.

Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.

Clin Ther. 2009 Aug;31(8):1765-73. doi: 10.1016/j.clinthera.2009.08.007.

PMID:
19808135
16.

Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.

Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T.

Sleep Med. 2013 Oct;14(10):955-63. doi: 10.1016/j.sleep.2013.04.010. Epub 2013 Aug 3.

PMID:
23920422
17.

Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial.

Williams SC, Marshall NS, Kennerson M, Rogers NL, Liu PY, Grunstein RR.

Am J Respir Crit Care Med. 2010 Apr 15;181(8):825-31. doi: 10.1164/rccm.200908-1307OC. Epub 2010 Jan 7.

PMID:
20056901
18.

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.

Lavault S, Dauvilliers Y, Drouot X, Leu-Semenescu S, Golmard JL, Lecendreux M, Franco P, Arnulf I.

Sleep Med. 2011 Jun;12(6):550-6. doi: 10.1016/j.sleep.2011.03.010. Epub 2011 May 14.

PMID:
21576035
19.
20.

Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy.

Sangal RB, Sangal JM, Belisle C.

Clin Neurophysiol. 1999 Jun;110(6):1041-7.

PMID:
10402091

Supplemental Content

Support Center